CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Support repeal of medical device tax. Support extension of R&D tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Health Issues HCR
Address concerns regarding uncertainty and unpredictability of FDA drug and device regulatory environment. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Support HR 2182, the Generating Antibiotic Incentives Now (GAIN) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Medicare/Medicaid MMM
Address concerns with Medicare Independent Payment Advisory Board (IPAB). Oppose changes to Medicare Part B (ASP) and Part D (expansion of dual eligible rebates).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Budget/Appropriations BUD
Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpilefunding and preparation; FDA Appropriations. Support protection of US law regarding biosimilars (12 years data exclusivity).
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD E GILLENWATER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.